Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion type Assertion NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_head.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion description "[Several studies have reported that a high expression ratio of HOXB13 to IL17BR predicts tumor recurrence in node-negative, estrogen receptor (ER) alpha-positive breast cancer patients treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_provenance.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion evidence source_evidence_literature NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_provenance.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion SIO_000772 18499701 NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_provenance.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion wasDerivedFrom befree-20140225 NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_provenance.
- NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_assertion wasGeneratedBy ECO_0000203 NP735014.RAixJlwgNM88SLsx3VzgnZ3GhpwphKSYlw_E9P-WsyV2A130_provenance.